Johnson & Johnson's Biosense Webster’s MaryAnn Edzards Joins BioSig

Former New Technology Education Manager to Assist with First Installations Santa Monica, CA, Dec. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has appointed Mrs. MaryAnn Edzards as Senior Director - Account Manager. Mrs. Edzards brings to the Company over…